Literature DB >> 17920693

Whole blood BDNF levels in healthy twins discordant for affective disorder: association to life events and neuroticism.

Viktorija Trajkovska1, Maj Vinberg, Susana Aznar, Gitte M Knudsen, Lars V Kessing.   

Abstract

BACKGROUND: Depression has been associated with decreased blood BDNF concentrations; but it is unclear if low blood BDNF levels are a state or a trait marker of depression.
METHODS: We investigated blood BDNF concentrations in a twin population including both subjects highly predisposed and protected against affective disorder. Whole blood assessed for BDNF concentrations and correlated to risk status, neuroticism, and number of stressful life events.
RESULTS: Between the groups, we found no significant difference in whole blood BDNF levels. Women at high-risk for depression who had experienced three or more recent stressful events (n=26) had decreased whole blood BDNF levels compared to high-risk women with two or less recent stressful events (n=35), 21.6+/-7.0 vs. 18.5+/-4.1 ng/ml, respectively, (p<0.05). No such association was found in low-risk women or in men. In men, however, low neuroticism scores and two or less recent stressful events were associated with decreased whole blood BDNF levels (n=50, p<0.05). LIMITATIONS: The cross-sectional design limits the possibility of drawing firm conclusions on causatility of the findings.
CONCLUSION: The genetic risk of developing depression does not translate directly into whole blood BDNF levels. In females who are genetically disposed for depression and subjected to recent stressful life events whole blood BDNF levels are lower.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920693     DOI: 10.1016/j.jad.2007.09.004

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.

Authors:  Anders Bue Klein; Viktorija Trajkovska; David Erritzoe; Steven Haugbol; Jacob Madsen; William Baaré; Susana Aznar; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

2.  Structural MRI correlates for vulnerability and resilience to major depressive disorder.

Authors:  Francesco Amico; Eva Meisenzahl; Nicolaos Koutsouleris; Maximilian Reiser; Hans-Juergen Möller; Thomas Frodl
Journal:  J Psychiatry Neurosci       Date:  2011-01       Impact factor: 6.186

3.  The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met.

Authors:  Bernet M Elzinga; Marc L Molendijk; Richard C Oude Voshaar; Boudewijn A A Bus; Jos Prickaerts; Philip Spinhoven; Brenda J W H Penninx
Journal:  Psychopharmacology (Berl)       Date:  2010-08-12       Impact factor: 4.530

4.  Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment.

Authors:  M L Molendijk; B A A Bus; Ph Spinhoven; B W J H Penninx; G Kenis; J Prickaerts; R C Oude Voshaar; B M Elzinga
Journal:  Mol Psychiatry       Date:  2010-09-21       Impact factor: 15.992

5.  Serum BDNF levels in unaffected first-degree relatives of patients with bipolar disorder.

Authors:  Fabiano G Nery; Alexandre D Gigante; Jose A Amaral; Francy B Fernandes; Mariangeles Berutti; Karla M Almeida; Laura Stertz; Giovana Bristot; Flavio Kapczinski; Beny Lafer
Journal:  Braz J Psychiatry       Date:  2016-02-05       Impact factor: 2.697

Review 6.  Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress.

Authors:  Kanchan Bisht; Kaushik Sharma; Marie-Ève Tremblay
Journal:  Neurobiol Stress       Date:  2018-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.